| Mid and long-term neurological and neuropsychiatric manifestations of post-COVID-19 syndrome: A meta-analysis L Premraj, NV Kannapadi, J Briggs, SM Seal, D Battaglini, J Fanning, ... Journal of the neurological sciences 434, 120162, 2022 | 529 | 2022 |
| Structure, function and pathophysiology of protease activated receptors MN Adams, R Ramachandran, MK Yau, JY Suen, DP Fairlie, ... Pharmacology & therapeutics 130 (3), 248-282, 2011 | 464 | 2011 |
| Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease MD Hollenberg, K Mihara, D Polley, JY Suen, A Han, DP Fairlie, ... British journal of pharmacology 171 (5), 1180-1194, 2014 | 204 | 2014 |
| C5aR and C3aR antagonists each inhibit diet-induced obesity, metabolic dysfunction, and adipocyte and macrophage signaling J Lim, A Iyer, JY Suen, V Seow, RC Reid, L Brown, DP Fairlie The FASEB Journal 27 (2), 822-831, 2013 | 152 | 2013 |
| Diet-induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism J Lim, A Iyer, L Liu, JY Suen, RJ Lohman, V Seow, MK Yau, L Brown, ... The FASEB Journal 27 (12), 4757-4767, 2013 | 131 | 2013 |
| Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110) JY Suen, GD Barry, RJ Lohman, MA Halili, AJ Cotterell, GT Le, DP Fairlie British journal of pharmacology 165 (5), 1413-1423, 2012 | 131 | 2012 |
| Novel agonists and antagonists for human protease activated receptor 2 GD Barry, JY Suen, GT Le, A Cotterell, RC Reid, DP Fairlie Journal of medicinal chemistry 53 (20), 7428-7440, 2010 | 130 | 2010 |
| An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats RJ Lohman, AJ Cotterell, GD Barry, L Liu, JY Suen, DA Vesey, DP Fairlie The FASEB Journal 26 (7), 2877-2887, 2012 | 124 | 2012 |
| Antagonism of protease-activated receptor 2 protects against experimental colitis RJ Lohman, AJ Cotterell, J Suen, L Liu, AT Do, DA Vesey, DP Fairlie Journal of Pharmacology and Experimental Therapeutics 340 (2), 256-265, 2012 | 111 | 2012 |
| Inflammatory responses induced by lipopolysaccharide are amplified in primary human monocytes but suppressed in macrophages by complement protein C5a V Seow, J Lim, A Iyer, JY Suen, JK Ariffin, DM Hohenhaus, MJ Sweet, ... The Journal of Immunology 191 (8), 4308-4316, 2013 | 104 | 2013 |
| Venovenous extracorporeal membrane oxygenation in patients with acute covid-19 associated respiratory failure: comparative effectiveness study M Urner, AG Barnett, GL Bassi, D Brodie, HJ Dalton, ND Ferguson, ... bmj 377, 2022 | 88 | 2022 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 86 | 2021 |
| ECMO use in COVID-19: lessons from past respiratory virus outbreaks—a narrative review HJ Cho, S Heinsar, IS Jeong, K Shekar, GL Bassi, JS Jung, JY Suen, ... Critical Care 24 (1), 1-8, 2020 | 81 | 2020 |
| Pathway‐selective antagonism of proteinase activated receptor 2 JY Suen, A Cotterell, RJ Lohman, J Lim, A Han, MK Yau, L Liu, ... British journal of pharmacology 171 (17), 4112-4124, 2014 | 77 | 2014 |
| A potent antagonist of protease-activated receptor 2 that inhibits multiple signaling functions in human cancer cells Y Jiang, MK Yau, J Lim, KC Wu, W Xu, JY Suen, DP Fairlie Journal of Pharmacology and Experimental Therapeutics 364 (2), 246-257, 2018 | 65 | 2018 |
| Profiling gene expression induced by protease-activated receptor 2 (PAR2) activation in human kidney cells JY Suen, B Gardiner, S Grimmond, DP Fairlie PLoS One 5 (11), e13809, 2010 | 62 | 2010 |
| An inhibitor of phospholipase A2 group IIA modulates adipocyte signaling and protects against diet-induced metabolic syndrome in rats A Iyer, J Lim, H Poudyal, RC Reid, JY Suen, J Webster, JB Prins, ... Diabetes 61 (9), 2320-2329, 2012 | 61 | 2012 |
| Low flow rate alters haemostatic parameters in an ex-vivo extracorporeal membrane oxygenation circuit KK Ki, MR Passmore, CHH Chan, MV Malfertheiner, JP Fanning, ... Intensive care medicine experimental 7 (1), 1-15, 2019 | 57 | 2019 |
| Therapeutic inhibition of acid-sensing ion channel 1a recovers heart function after ischemia–reperfusion injury MA Redd, SE Scheuer, NJ Saez, Y Yoshikawa, HS Chiu, L Gao, M Hicks, ... Circulation 144 (12), 947-960, 2021 | 53 | 2021 |
| Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium … LF Reyes, S Murthy, E Garcia-Gallo, M Irvine, L Merson, I Martin-Loeches, ... ERJ open research 8 (1), 2022 | 52 | 2022 |
Fraser JFProfessor, Faculty of Medicine, University of Queensland在 uq.edu.au 的电子邮件经过验证
